IL6 and obesity disorder: In contrast, in WAT dysfunction in obesity, pro-atherogenic factors, such as FFAs, TNF-α, IL-6, resistin, and leptin, are secreted, which increase the development of atherosclerosis, internal plaque inflammation, and plaque vulnerability [246].